171 related articles for article (PubMed ID: 11479042)
1. Medical management of cutaneous malignancies.
Gibbs P; Gonzalez R; Lee LA; Walsh P
Clin Dermatol; 2001; 19(3):298-304. PubMed ID: 11479042
[No Abstract] [Full Text] [Related]
2. [Cytokines: current status and prospects in the treatment of skin tumors].
Nashan D; Luger TA
Hautarzt; 2001 Aug; 52(8):691-6. PubMed ID: 11544938
[TBL] [Abstract][Full Text] [Related]
3. [Cutaneous neoplasms].
Dummer R; Beyeler M; Morcinek J; Burg G
Praxis (Bern 1994); 2003 Sep; 92(36):1470-8. PubMed ID: 14526630
[TBL] [Abstract][Full Text] [Related]
4. Advances in the Treatment of Advanced Extracutaneous Melanomas and Nonmelanoma Skin Cancers.
Komatsubara KM; Jeter J; Carvajal RD; Margolin K; Schadendorf D; Hauschild A
Am Soc Clin Oncol Educ Book; 2017; 37():641-650. PubMed ID: 28561682
[TBL] [Abstract][Full Text] [Related]
5. Photoradiation therapy for cutaneous and subcutaneous malignant tumors using hematoporphyrin.
Tomio L; Calzavara F; Zorat PL; Corti L; Polico C; Reddi E; Jori G; Mandoliti G
Prog Clin Biol Res; 1984; 170():829-40. PubMed ID: 6531372
[No Abstract] [Full Text] [Related]
6. [Cytostatic agents in dermatology].
Luger A
Z Hautkr; 1978 Dec; 53(23):857-70. PubMed ID: 726543
[No Abstract] [Full Text] [Related]
7. Molecularly targeted therapies for nonmelanoma skin cancers.
Liu LS; Colegio OR
Int J Dermatol; 2013 Jun; 52(6):654-65. PubMed ID: 23679874
[TBL] [Abstract][Full Text] [Related]
8. The Landmark Series: Non-melanoma Skin Cancers.
Lee AY; Berman RS
Ann Surg Oncol; 2020 Jan; 27(1):22-27. PubMed ID: 31549317
[TBL] [Abstract][Full Text] [Related]
9. Review of Targeted Therapies for Periocular Tumors.
Mehta VJ; Ling J; Sobel RK
Int Ophthalmol Clin; 2017; 57(1):153-168. PubMed ID: 27898621
[No Abstract] [Full Text] [Related]
10. Immune checkpoint inhibitors to treat cutaneous malignancies.
Barrios DM; Do MH; Phillips GS; Postow MA; Akaike T; Nghiem P; Lacouture ME
J Am Acad Dermatol; 2020 Nov; 83(5):1239-1253. PubMed ID: 32461079
[TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy of skin and soft tissue tumors].
Herrmann R
Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():919-21. PubMed ID: 1983679
[TBL] [Abstract][Full Text] [Related]
12. Electrochemotherapy for the management of cutaneous and subcutaneous metastasis: a series of 39 patients treated with palliative intent.
Solari N; Spagnolo F; Ponte E; Quaglia A; Lillini R; Battista M; Queirolo P; Cafiero F
J Surg Oncol; 2014 Mar; 109(3):270-4. PubMed ID: 24165992
[TBL] [Abstract][Full Text] [Related]
13. Systemic therapy of skin carcinoma.
Kempf RA
Cancer Treat Res; 1995; 78():137-62. PubMed ID: 8595141
[No Abstract] [Full Text] [Related]
14. Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients.
O'Reilly Zwald F; Brown M
J Am Acad Dermatol; 2011 Aug; 65(2):253-261. PubMed ID: 21763561
[TBL] [Abstract][Full Text] [Related]
15. Electrochemotherapy of unresectable cutaneous tumours with reduced dosages of intravenous bleomycin: analysis of 57 patients from the International Network for Sharing Practices of Electrochemotherapy registry.
Rotunno R; Campana LG; Quaglino P; de Terlizzi F; Kunte C; Odili J; Gehl J; Ribero S; Liew SH; Marconato R; Brizio M; Curatolo P
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1147-1154. PubMed ID: 29178483
[TBL] [Abstract][Full Text] [Related]
16. Skin cancer treatment options: new horizons and promises for the future.
Semkova K; Tchernev G; Wollina U
Wien Med Wochenschr; 2013 Aug; 163(15-16):345-6. PubMed ID: 23846703
[No Abstract] [Full Text] [Related]
17. The role of electrochemotherapy in the treatment of metastatic head and neck cancer.
De Virgilio A; Fusconi M; Greco A; de Vincentiis M
Tumori; 2013; 99(5):634. PubMed ID: 24362869
[No Abstract] [Full Text] [Related]
18. Review of a 3-year experience with topical chemotherapy and immunotherapy of superficial cutaneous neoplasms.
Cavins JA
J Surg Oncol; 1971; 3(3):325-9. PubMed ID: 5110337
[No Abstract] [Full Text] [Related]
19. Imiquimod to treat basal cell and squamous cell carcinomas.
Keller CD
Am Fam Physician; 2005 Jul; 72(1):41. PubMed ID: 16035682
[No Abstract] [Full Text] [Related]
20. Topical imiquimod monotherapy for a recurrent lesion of Merkel cell carcinoma.
Miura H; Takada M; Fujiwara M; Fujiwara S
Br J Dermatol; 2021 Feb; 184(2):e30. PubMed ID: 32845515
[No Abstract] [Full Text] [Related]
[Next] [New Search]
